Trial intelligence / Profile preview

Dibotatug in Bone Marrow Failure Syndromes

NCT07712562Phase 2Recruiting

Sponsor
Dren Bio
Start
Aug 2026
Primary completion
Apr 2029
Countries
1
01

Overview

A Phase 2 trial of dibotatug in aplastic anemia, sponsored by Dren Bio. Started Aug 2026; status: recruiting.

02

Drugs

dibotatug
03

Conditions

aplastic anemia

Beyond the preview

Go deeper on NCT07712562.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07712562.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call